Published in Mycologia on May 20, 1966
The Isolation of a Mucopolysaccharide from Aerobacter aerogenes. Science (1950) 1.95
Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med (1974) 1.76
Experimental Campylobacter jejuni infection of adult mice. Infect Immun (1983) 1.74
Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol Cell Biol (1999) 1.51
The prognostic significance of penicillin serum levels and protein binding in clinical medicine. A review of current studies. Chemotherapy (1967) 1.46
Antimicrobial activity and pharmacological distribution of Wy-4508, an aminoalicyclic penicillin. Antimicrob Agents Chemother (Bethesda) (1967) 1.19
Purification and properties of a beta-lactamase from Proteus penneri. J Antibiot (Tokyo) (1986) 1.10
Antibody-mediated bacteriolysis: enhanced killing of cyclacillin-treated bacteria. Proc Soc Exp Biol Med (1976) 1.07
Relapse of Hemophilus influenzae type b meningitis during intravenous therapy with ampicillin. J Pediatr (1969) 1.04
Electron microscopic study of the action of nafcillin on Staphylococcus aureus. Chemotherapy (1968) 0.95
Obstructive cholangitis secondary to mucus secreted by a solitary papillary bile duct tumor. Gastroenterology (1986) 0.95
Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones. Chemotherapy (1986) 0.95
Endoscopic sclerotherapy for bleeding esophageal varices: effects and complications. Ann Intern Med (1983) 0.93
The pharmacology of penamecillin. Br J Pharmacol Chemother (1966) 0.88
Therapeutic activity of aminoalicyclic penicillins in bacterial infections in mice. Antimicrob Agents Chemother (Bethesda) (1967) 0.87
Effect of cyclacillin and ampicillin on the gut flora of mice. Chemotherapy (1980) 0.87
Collagenous colitis with involvement of terminal ileum. Dig Dis Sci (1991) 0.87
The biliary tract in inflammatory bowel disease. Clin Gastroenterol (1983) 0.87
Cocaine-induced hepatotoxicity in humans. Gastroenterology (1987) 0.86
The haematopoietic response to burning: an autopsy study. Burns Incl Therm Inj (1985) 0.85
Effect of sublethal concentrations of penicillins on the lysis of bacteria by lysozyme and trypsin. Proc Soc Exp Biol Med (1965) 0.85
Increased phagocytosis of Escherichia coli pretreated with subinhibitory concentrations of cyclacillin or ampicillin. Proc Soc Exp Biol Med (1982) 0.85
Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice. J Antimicrob Chemother (1987) 0.84
Toxicity studies of lorazepam, a new benzodiazepine, in animals. Arzneimittelforschung (1971) 0.83
Esophageal ulceration and bleeding after flexible fiberoptic esophageal vein sclerosis. Gastroenterology (1982) 0.83
Cultivation and survival studies of Neisseria gonorrhoeae in a human diploid cell strain. Yale J Biol Med (1974) 0.82
Calcified endobronchial mass in a 28-year-old man. Chest (1990) 0.82
Antitubercular Diazine Carboxamides. Science (1952) 0.82
Search for a specific marker of mucosal dysplasia in chronic ulcerative colitis. Gastroenterology (1987) 0.81
Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases. Drugs Exp Clin Res (1987) 0.80
Duration of therapeutic activity of aminoalicyclic penicillins against bacterial infections in mice. Antimicrob Agents Chemother (Bethesda) (1967) 0.79
Nitrofurantoin-induced cholestatic hepatitis from cow's milk in a teenaged boy. West J Med (1984) 0.78
Effect of disruption of the sebaceous layer of the sheep's skin on the incidence of fleece-rot. Aust Vet J (1979) 0.78
Characterization of calcium deprivation-induced cholestasis in the perfused rat liver. Am J Physiol (1985) 0.78
The use of infrared photoplethysmography in identifying early intestinal ischemia. Arch Surg (1987) 0.77
Inflammatory polyposis in an ileal blind loop. Gastroenterology (1983) 0.77
Reversal of antileukemic action and toxicity of 1-aminocyclopentanecarboxylic acid in mice by L-valine. Cancer Res (1969) 0.77
Development of cataracts in dogs and rats from prolonged feeding of sulfaethoxypyridazine. Toxicol Appl Pharmacol (1967) 0.76
Mood changes during three conditions of alcohol intake. Q J Stud Alcohol (1972) 0.76
Synergistic activity of apalcillin and gentamicin in a combination therapy in experimental Pseudomonas bacteraemia of neutropenic mice. J Antimicrob Chemother (1986) 0.76
Bullet embolism from the head to the heart. JAMA (1974) 0.76
Fulminant hepatic failure associated with intravenous erythromycin lactobionate. Arch Intern Med (1990) 0.75
Anti-tumour and anti-metastatic activity of 3-(P-Chlorophenyl)-2,3-Dihydro-3-Hydroxythiazolo (3,2-A)-Benzimidazole-2-acetic acid (WY-13,876). Br J Cancer (1976) 0.75
Evaluational set and creativity. Percept Mot Skills (1972) 0.75
Immunomodulating activity of 3-(p-chlorophenyl)thiazolo-[3,2-a] benzimidazole-2-acetic acid (Wy-18,251, NSC 310633) in mice implanted with Lewis lung tumor. Effect of Wy-18,251 on lymphocyte proliferation and phagocytosis. J Immunopharmacol (1983) 0.75
Sex- and species-related nephropathy of 6-(1-aminocyclohexanecarboxamido)penicillanic acid (cyclacillin) and its relationship to the metabolic disposition of the drug. Toxicol Appl Pharmacol (1974) 0.75
Cyclacillin-induced potentiation of Escherichia coli immunogenicity in vivo and in vitro. Chemotherapy (1977) 0.75
Carcinoma arising in a tracheostomy scar. Arch Otolaryngol (1983) 0.75
A PROPOSED BIOGRAPHICAL ENTOMOLOGICAL DICTIO NARY. Science (1924) 0.75
Plasma 17-hydroxycorticosteroid patterns; tends in toxemia. Obstet Gynecol (1966) 0.75
Substituted penicillin amides. Duration of antibacterial activity (depot effect) in experimental infections in mice. Chemotherapy (1972) 0.75
Amide Penicillin Wy-12,556: therapeutic activity in animals subjected to repeated bacterial infection. Chemotherapy (1976) 0.75
Metabolic and pathologic investigation of 1-aminocyclohexanecarboxylic acid (ACHC), a metabolite of 6-(1-aminocyclohexanecarboxamido)-penicillanic acid (cyclacillin). Toxicol Appl Pharmacol (1974) 0.75
NEMATODES ON MARKETABLE FISHES. Science (1918) 0.75
Technical aspects of sclerotherapy. Gastroenterology (1982) 0.75
Immunomodulating and antimetastatic activity of 3-(p-chlorophenyl) thiazolo[3,2-a]benzimidazole-2-acetic acid (Wy-18,251, NSC 310633). J Immunopharmacol (1980) 0.75
Granulomatous Torulopsis glabrata cholecystitis in a diabetic. Am J Clin Pathol (1982) 0.75
Inhibitory activity of cefpiramide on beta-lactamase. Chemotherapy (1985) 0.75
Cyclacillin: microbiological and pharmacological properties and use in chemotherapy of infection - a critical appraisal. Chemotherapy (1976) 0.75
Therapeutic efficacy of cefpiramide and cefoperazone alone and in combination with gentamicin against pseudomonal infections in neutropenic mice. Chemotherapy (1986) 0.75
Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin. Drugs Exp Clin Res (1985) 0.75
Toxicity of a hypoglycemic agent, 2-p-methoxybenzene-sulfonamido-5-isobutyl-1,3,4-thiadiazole. Toxicol Appl Pharmacol (1966) 0.75
Nafcillin and oxacillin: comparative antistaphylococcal activity in mice. J Antibiot (Tokyo) (1976) 0.75
The in vitro action of mammalian sex hormones on Staphylococcus aureus. Chemotherapy (1970) 0.75
Effect of antimicrobial drug combinations on enzymic lysis of Staphylococcus aureus. Proc Soc Exp Biol Med (1967) 0.75
Stimulation by a hydroxythiazolobenzimidazole of enhanced formation of antibodies to sheep erythrocytes in vitro and in vivo. Immunopharmacology (1979) 0.75
Immunomodulating effects in vitro of a hydroxythiazolobenzimidazole in the absence of mitogenicity. Experientia (1978) 0.75
Serum concentrations of sodium nafcillin in infants during the perinatal period. Antimicrob Agents Chemother (Bethesda) (1965) 0.75
Antimicrobial activity of cyclacillin against Escherichia coli in vivo and in vitro. Experientia (1971) 0.75
Effect of mixtures of atabrine and antibacterial agents on the emergence of resistant strains of Mycobacterium tuberculosis. Nature (1967) 0.75
Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Drugs Exp Clin Res (1987) 0.75
Cyclacillin, a semisynthetic aminoalicyclic penicillin. I. Antibacterial activity in vitro and in vivo compared with ampicillin and cephalexin. Chemotherapy (1970) 0.75
Degradation of penicillin G and three semisynthetic penicillins by Bacillus cereus and Staphylococcus aureus penicillinase. Can J Microbiol (1966) 0.75
Effect of L-valine on renal excretion, blood concentrations and toxicity of cycloleucine in mice. Biochem Pharmacol (1973) 0.75
Effects of the interaction of penicillins with other antimicrobial agents of the enzymic lysis of Staphylococcus aureus. Proc Soc Exp Biol Med (1968) 0.75
A morphometric analysis of the changes with age in the skin surface wax and the sebaceous gland area of Merino sheep. Aust Vet J (1983) 0.75
FESTSCHRIFT OF PROFESSOR EMBRIK STRAND. Science (1941) 0.75
Toxicity of some benzodiazepine compounds with CNS activity. Toxicol Appl Pharmacol (1970) 0.75
Biopharmaceuticals approved in the EU 1995-1999: a European Union-United States comparison. Eur J Pharm Biopharm (2001) 0.75
Antitumor activity of periodate-oxidation products of carbohydrates and their derivatives. Cancer Res (1966) 0.75
Antitubercular activity of substituted 5-oxo-1-thiocarbamoyl-3-pyrazoline-4-alkanoic acid derivatives. J Pharm Sci (1975) 0.75